| Outcome Measures: |
Primary: Change From Baseline in A1C at Week 20, Glycated hemoglobin (A1C) is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100. Mean change from baseline at Week 20 was estimated from a longitudinal data analysis model., Baseline and Week 20|Number of Participants Who Experienced ≥1 Adverse Event During Weeks 0-20, The number of participants experiencing ≥1 adverse event during Weeks 0-20 was reported. An adverse event is defined as any untoward medical occurrence in a person administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment., Up to Week 20|Number of Participants Who Discontinued Study Drug Due to Experiencing an Adverse Event During Weeks 0-20, The number of participants who discontinued from study drug due to an adverse event during Weeks 0-20 was reported. An adverse event is defined as any untoward medical occurrence in a person administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment., Up to Week 20|Number of Participants Who Experienced ≥1 Adverse Event During Weeks 0-56, The number of participants experiencing ≥1 adverse event during Weeks 0-56 were reported. An adverse event is defined as any untoward medical occurrence in a person administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment., Up to approximately Week 56|Number of Participants Who Discontinued Study Drug Due to Experiencing an Adverse Event During Weeks 0-54, The number of participants who discontinued from study drug due to an adverse event during Weeks 0-54 was reported. An adverse event is defined as any untoward medical occurrence in a person administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment., Up to Week 54 | Secondary: Change From Baseline in A1C at Week 54, A1C is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100. Mean change from baseline at Week 54 was estimated from a longitudinal data analysis model., Baseline and Week 54|Change From Baseline in Fasting Plasma Glucose (FPG) at Week 20, Blood glucose was measured on a fasting basis. Mean change from baseline at Week 20 was estimated from a longitudinal data analysis model., Baseline and Week 20|Change From Baseline in FPG at Week 54, Blood glucose was measured on a fasting basis. Mean change from baseline at Week 54 was estimated from a longitudinal data analysis model., Baseline and Week 54|Percentage of Participants With A1C at Goal (<7.0%) at Week 20, Glycated hemoglobin (A1C) is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100. Percentage of participants with A1C at goal (\<7.0%) at Week 20 was presented., Week 20|Percentage of Participants With A1C at Goal (<6.5%) at Week 20, Glycated hemoglobin (A1C) is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100. Percentage of participants with A1C at goal (\<6.5%) at Week 20 was presented., Week 20|Percentage of Participants With A1C at Goal (<7.0%) at Week 54, Glycated hemoglobin (A1C) is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100. Percentage of participants with A1C at goal (\<7.0%) at Week 54 was presented., Week 54|Percentage of Participants With A1C at Goal (<6.5%) at Week 54, Glycated hemoglobin (A1C) is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100. Percentage of participants with A1C at goal (\<6.5%) at Week 54 was presented., Week 54|Percentage of Participants Initiating Glycemic Rescue Therapy by Week 20, Percentage of participants who initiated glycemic rescue therapy prior to Week 20 was reported., Up to Week 20|Percentage of Participants Initiating Insulin Glargine During Weeks 20-54, Percentage of participants who initiated insulin glargine therapy from Weeks 20 through 54 was reported., Week 20 up to Week 54 | Other: Baseline A1C, Glycated hemoglobin (A1C) is a blood marker used to report average blood glucose levels over prolonged periods of time. Percentage A1C is the ratio of glycated hemoglobin to total hemoglobin x 100., Baseline
|
